Q1
MDT — Q1 FY2027 (Quarter Ended July 31, 2026) Financial Report Analysis
Medtronic's revenue rose 13.7% to $9.76B, about 7% organic once an extra week is excluded, as electrophysiology sales jumped 29.5% on pulsed field ablation. GAAP EPS rose to $1.14 from $0.81 and FY27 guidance was raised.